{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:02:35Z","timestamp":1789448555372,"version":"build-2803163510"},"reference-count":154,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Alzheimer Society Southwest Partners Scholarships"},{"name":"Canada Graduate Research Scholarship"},{"name":"Western Institute for Neuroscience Translational Postdoctoral Fellowship"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/01gavpb45","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004089","name":"Krembil Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004089","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/037svw098","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/000az4664","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Ontario Institute for Cancer Research"},{"id":[{"id":"https:\/\/ror.org\/043q8yx54","id-type":"ROR","asserted-by":"publisher"}]},{"name":"National Football League"},{"id":[{"id":"https:\/\/ror.org\/05w75gv97","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Tauopathies comprise a heterogeneous group of neurological and systemic disorders characterized by pathological tau dysregulation, traditionally including Alzheimer\u2019s disease (AD), traumatic brain injury (TBI), and chronic traumatic encephalopathy (CTE). Emerging evidence suggests that tauopathy may also occur in selected vascular and systemic disease contexts, including ischemic stroke, vascular dementia (VaD), and preeclampsia (PE), although the strength and clinical significance of this evidence vary among these conditions. Compelling evidence suggests that the Pin1-cis phosphorylated tau (cis P-tau) axis may represent a convergent molecular mechanism linking these conditions. Pin1 is a phosphorylation-specific peptidyl-prolyl cis-trans isomerase that protects against tauopathy and cognitive impairment by catalyzing conversion of pathological cis P-tau to the physiological trans conformation at phosphorylated Thr231-Pro motifs. Under stress conditions such as oxidative stress, hypoxia, inflammation, mechanical injury, or aging, Pin1 activity becomes impaired through oxidation, phosphorylation, sequestration, or transcriptional downregulation, resulting in the accumulation of neurotoxic cis P-tau. cis P-tau is proposed to initiate a pathogenic cascade termed cistauosis in neurons, characterized by axonal microtubule collapse and transport failure, mitochondrial dysfunction, synaptic degeneration, neuroinflammation, neuronal death, and prion-like spread. Importantly, cis P-tau appears rapidly after insults long before overt neurofibrillary tangle (NFT) formation in several experimental and clinical contexts, supporting its role as an upstream pathogenic driver and early biomarker. Crucially, conformation-specific monoclonal antibodies targeting cis P-tau selectively eliminate pathological cis P-tau while sparing physiological trans P-tau, demonstrating promising therapeutic effects in preclinical models of TBI, vascular injury, AD-related tauopathy, and PE. This review summarizes the molecular basis of the Pin1\u2013cis P-tau axis, examines its role across conventional and unconventional tauopathies, evaluates its biomarker potential, and highlights cis-specific immunotherapy as a potentially broad therapeutic strategy for neurodegenerative, traumatic, and vascular cognitive disorders.<\/jats:p>","DOI":"10.3390\/cells15181650","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:10:23Z","timestamp":1789373423000},"page":"1650","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Pin1\u2013cis P-tau Axis: A Key Common Early Pathogenic Driver, Biomarker and Therapeutic Target Across Neurodegenerative, Traumatic, and Vascular Cognitive Disorders"],"prefix":"10.3390","volume":"15","author":[{"given":"Zhixiong","family":"Li","sequence":"first","affiliation":[{"name":"Departments of Biochemistry and Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"},{"name":"Robarts Research Institute, Western University, London, ON N6A 5B7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Li","sequence":"additional","affiliation":[{"name":"Departments of Biochemistry and Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"},{"name":"Robarts Research Institute, Western University, London, ON N6A 5B7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4106-2709","authenticated-orcid":false,"given":"Rui","family":"Liu","sequence":"additional","affiliation":[{"name":"Departments of Biochemistry and Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"},{"name":"Department of Physiology and Pharmacology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanming Michelle","family":"Zhu","sequence":"additional","affiliation":[{"name":"Departments of Biochemistry and Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"},{"name":"Robarts Research Institute, Western University, London, ON N6A 5B7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhi","family":"Wang","sequence":"additional","affiliation":[{"name":"Departments of Biochemistry and Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"},{"name":"Robarts Research Institute, Western University, London, ON N6A 5B7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0734-1567","authenticated-orcid":false,"given":"Kun Ping","family":"Lu","sequence":"additional","affiliation":[{"name":"Departments of Biochemistry and Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"},{"name":"Robarts Research Institute, Western University, London, ON N6A 5B7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7849-2116","authenticated-orcid":false,"given":"Xiao Zhen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Departments of Biochemistry and Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"},{"name":"Department of Pathology and Laboratory Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"},{"name":"Lawson Health Research Institute, Western University, London, ON N6C 2R5, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","author":"Spillantini","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_3","first-page":"327","article-title":"Alzheimer\u2019s disease facts and figures","volume":"17","author":"Yang","year":"2021","journal-title":"Alzheimers Dement."},{"key":"ref_4","unstructured":"GBD 2019 Dementia Forecasting Collaborators (2022). Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019. Lancet Public Health, 7, e105\u2013e125."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/aws307","article-title":"The spectrum of disease in chronic traumatic encephalopathy","volume":"136","author":"McKee","year":"2013","journal-title":"Brain"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1590\/1980-57642015DN94000356","article-title":"Dementia resulting from traumatic brain injury","volume":"9","author":"Ramalho","year":"2015","journal-title":"Dement. Neuropsychol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mcn.2015.03.001","article-title":"Epidemiology of mild traumatic brain injury and neurodegenerative disease","volume":"66","author":"Gardner","year":"2015","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jama.2015.6968","article-title":"Trajectory of Cognitive Decline After Incident Stroke","volume":"314","author":"Levine","year":"2015","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e70041","DOI":"10.1002\/pmf2.70041","article-title":"Association of preeclampsia with long-term risk of neurodegenerative disorders","volume":"1","author":"Bazan","year":"2025","journal-title":"Pregnancy"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1038\/s41467-023-41144-6","article-title":"Cis P-tau is a central circulating and placental etiologic driver and therapeutic target of preeclampsia","volume":"14","author":"Jash","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/s41467-017-01068-4","article-title":"Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae","volume":"8","author":"Albayram","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"eaaz7615","DOI":"10.1126\/scitranslmed.aaz7615","article-title":"Cis P-tau underlies vascular contribution to cognitive impairment and dementia and can be effectively targeted by immunotherapy in mice","volume":"13","author":"Qiu","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature14658","article-title":"Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy","volume":"523","author":"Kondo","year":"2015","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A century of Alzheimer\u2019s disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.1228541","article-title":"Preventing Alzheimer\u2019s disease","volume":"337","author":"Selkoe","year":"2012","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.arcmed.2012.09.009","article-title":"Pathogenesis and disease-modifying therapy in Alzheimer\u2019s disease: The flat line of progress","volume":"43","author":"Castellani","year":"2012","journal-title":"Arch. Med. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","article-title":"Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice","volume":"6","author":"Sengupta","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer\u2019s disease","volume":"82","author":"Hyman","year":"2014","journal-title":"Neuron"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/pro.3499","article-title":"Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross-seeding behavior","volume":"27","author":"Ghag","year":"2018","journal-title":"Protein Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4161\/pri.22849","article-title":"Cis phosphorylated tau as the earliest detectable pathogenic conformation in Alzheimer disease, offering novel diagnostic and therapeutic strategies","volume":"7","author":"Nakamura","year":"2013","journal-title":"Prion"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.cell.2012.02.016","article-title":"Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer\u2019s disease","volume":"149","author":"Nakamura","year":"2012","journal-title":"Cell"},{"key":"ref_25","first-page":"1000443","article-title":"Targeting Prion-like Cis Phosphorylated Tau Pathology in Neurodegenerative Diseases","volume":"8","author":"Albayram","year":"2018","journal-title":"J. Alzheimers Dis. Park."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2014.12.027","article-title":"Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer\u2019s disease","volume":"76","author":"Chen","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Qiu, C., Li, Z., Leigh, D.A., Duan, B., Stucky, J.E., Kim, N., Xie, G., Lu, K.P., and Zhou, X.Z. (2024). The role of the Pin1-cis P-tau axis in the development and treatment of vascular contribution to cognitive impairment and dementia and preeclampsia. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1343962"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/jnc.15909","article-title":"Function and regulation of cis P-tau in the pathogenesis and treatment of conventional and nonconventional tauopathies","volume":"166","author":"Wang","year":"2023","journal-title":"J. Neurochem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.tibs.2011.07.001","article-title":"Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins","volume":"36","author":"Liou","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrm2261","article-title":"The prolyl isomerase PIN1: A pivotal new twist in phosphorylation signalling and disease","volume":"8","author":"Lu","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/21650","article-title":"The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein","volume":"399","author":"Lu","year":"1999","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.278.5345.1957","article-title":"Sequence-specific and phosphorylation-dependent proline isomerization: A potential mitotic regulatory mechanism","volume":"278","author":"Yaffe","year":"1997","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1097-2765(05)00083-3","article-title":"Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins","volume":"6","author":"Zhou","year":"2000","journal-title":"Mol. Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e2200138","DOI":"10.1002\/bies.202200138","article-title":"Tau, microtubule dynamics, and axonal transport: New paradigms for neurodegenerative disease","volume":"45","author":"Cario","year":"2023","journal-title":"Bioessays"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tcb.2019.02.007","article-title":"Tau: It\u2019s Not What You Think","volume":"29","author":"Baas","year":"2019","journal-title":"Trends Cell Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijbiomac.2019.04.120","article-title":"Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies","volume":"133","author":"Venkatramani","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s12035-020-02179-8","article-title":"The Peptidyl-prolyl Isomerase Pin1 in Neuronal Signaling: From Neurodevelopment to Neurodegeneration","volume":"58","author":"Fagiani","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature01832","article-title":"Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration","volume":"424","author":"Liou","year":"2003","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1385\/JMN:19:3:275","article-title":"Pin1: A therapeutic target in Alzheimer neurodegeneration","volume":"19","author":"Hamdane","year":"2002","journal-title":"J. Mol. Neurosci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0169-328X(86)90033-1","article-title":"Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2","volume":"387","author":"Neve","year":"1986","journal-title":"Mol. Brain Res."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Noble, W., Hanger, D.P., Miller, C.C., and Lovestone, S. (2013). The importance of tau phosphorylation for neurodegenerative diseases. Front. Neurol., 4.","DOI":"10.3389\/fneur.2013.00083"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.2174\/1566524011313070001","article-title":"Distinct functions of cis and trans phosphorylated tau in Alzheimer\u2019s disease and their therapeutic implications","volume":"13","author":"Nakamura","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/jamaneurol.2016.2027","article-title":"Potential of the Antibody Against cis-Phosphorylated Tau in the Early Diagnosis, Treatment, and Prevention of Alzheimer Disease and Brain Injury","volume":"73","author":"Lu","year":"2016","journal-title":"JAMA Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"eaaw9997","DOI":"10.1126\/science.aaw9997","article-title":"Axonal transport: Driving synaptic function","volume":"366","author":"Holzbaur","year":"2019","journal-title":"Science"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Sontag, J.M., and Sontag, E. (2014). Protein phosphatase 2A dysfunction in Alzheimer\u2019s disease. Front. Mol. Neurosci., 7.","DOI":"10.3389\/fnmol.2014.00016"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-4-13","article-title":"The role of tau in neurodegeneration","volume":"4","author":"Gendron","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1073\/pnas.0406361102","article-title":"Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.brainres.2011.07.052","article-title":"Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer\u2019s disease","volume":"1415","author":"Reddy","year":"2011","journal-title":"Brain Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrn3156","article-title":"Mitochondrial transport in neurons: Impact on synaptic homeostasis and neurodegeneration","volume":"13","author":"Sheng","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-981-32-9358-8_7","article-title":"Tau and Axonal Transport Misregulation in Tauopathies","volume":"1184","author":"Combs","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","article-title":"Propagation of tau pathology in a model of early Alzheimer\u2019s disease","volume":"73","author":"Polydoro","year":"2012","journal-title":"Neuron"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nn.4132","article-title":"Depletion of microglia and inhibition of exosome synthesis halt tau propagation","volume":"18","author":"Asai","year":"2015","journal-title":"Nat. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-016-0143-y","article-title":"The release and trans-synaptic transmission of Tau via exosomes","volume":"12","author":"Wang","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Perez, M., Avila, J., and Hernandez, F. (2019). Propagation of Tau via Extracellular Vesicles. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.00698"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"a024372","DOI":"10.1101\/cshperspect.a024372","article-title":"The Prion-Like Behavior of Assembled Tau in Transgenic Mice","volume":"7","author":"Clavaguera","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1445-5994.2006.01153.x","article-title":"Tauopathies: Classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau","volume":"36","author":"Williams","year":"2006","journal-title":"Intern. Med. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1212\/01.wnl.0000218161.15834.db","article-title":"Tau protein hyperphosphorylation in sporadic ALS with cognitive impairment","volume":"66","author":"Strong","year":"2006","journal-title":"Neurology"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Amabebe, E., Huang, Z., Jash, S., Krishnan, B., Cheng, S., Nakashima, A., Li, Y., Li, Z., Wang, R., and Menon, R. (2024). Novel Role of Pin1-Cis P-Tau-ApoE Axis in the Pathogenesis of Preeclampsia and Its Connection with Dementia. Biomedicines, 13.","DOI":"10.3390\/biomedicines13010029"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Chen, D., Wang, L., and Lee, T.H. (2020). Post-translational Modifications of the Peptidyl-Prolyl Isomerase Pin1. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00129"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.neurobiolaging.2005.05.005","article-title":"Oxidative modification and down-regulation of Pin1 in Alzheimer\u2019s disease hippocampus: A redox proteomics analysis","volume":"27","author":"Sultana","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.molcel.2011.03.005","article-title":"Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function","volume":"42","author":"Lee","year":"2011","journal-title":"Mol. Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/j.1471-4159.2006.03995.x","article-title":"Pin1 in Alzheimer\u2019s disease","volume":"98","author":"Butterfield","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.bbadis.2014.12.025","article-title":"Peroxide-mediated oxidation and inhibition of the peptidyl-prolyl isomerase Pin1","volume":"1852","author":"Innes","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neurobiolaging.2024.06.007","article-title":"Reduced PIN1 expression in neocortical and limbic brain regions in female Alzheimer\u2019s patients correlates with cognitive and neuropathological phenotypes","volume":"141","author":"Suazo","year":"2024","journal-title":"Neurobiol. Aging"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2007.01.023","article-title":"Temporal relationship of peroxynitrite-induced oxidative damage, calpain-mediated cytoskeletal degradation and neurodegeneration after traumatic brain injury","volume":"205","author":"Deng","year":"2007","journal-title":"Exp. Neurol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"102072","DOI":"10.1016\/j.pneurobio.2021.102072","article-title":"Inhibition of death-associated protein kinase 1 attenuates cis P-tau and neurodegeneration in traumatic brain injury","volume":"203","author":"Kim","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0969-9961(03)00109-8","article-title":"Pin1 colocalization with phosphorylated tau in Alzheimer\u2019s disease and other tauopathies","volume":"14","author":"Ramakrishnan","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"7968","DOI":"10.1074\/jbc.M112.433326","article-title":"Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclin-dependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites","volume":"288","author":"Kimura","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Ao, C., Li, C., Chen, J., Tan, J., and Zeng, L. (2022). The role of Cdk5 in neurological disorders. Front. Cell. Neurosci., 16.","DOI":"10.3389\/fncel.2022.951202"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1007\/s11596-023-2792-8","article-title":"P25\/CDK5-mediated Tau Hyperphosphorylation in Both Ipsilateral and Contralateral Cerebra Contributes to Cognitive Deficits in Post-stroke Mice","volume":"43","author":"Yu","year":"2023","journal-title":"Curr. Med. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Engmann, O., and Giese, K.P. (2009). Crosstalk between Cdk5 and GSK3beta: Implications for Alzheimer\u2019s Disease. Front. Mol. Neurosci., 2.","DOI":"10.3389\/neuro.02.002.2009"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.expneurol.2005.12.030","article-title":"Pin1 protein associates with neuronal lipofuscin: Potential consequences in age-related neurodegeneration","volume":"199","author":"Phillips","year":"2006","journal-title":"Exp. Neurol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"11343","DOI":"10.18632\/oncotarget.14526","article-title":"miR-874-3p is down-regulated in hepatocellular carcinoma and negatively regulates PIN1 expression","volume":"8","author":"Leong","year":"2017","journal-title":"Oncotarget"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.bbamcr.2014.06.001","article-title":"MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1","volume":"1843","author":"Lee","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"32742","DOI":"10.1074\/jbc.M113.478016","article-title":"Regulation of the microRNA 200b (miRNA-200b) by transcriptional regulators PEA3 and ELK-1 protein affects expression of Pin1 protein to control anoikis","volume":"288","author":"Zhang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.2174\/1567205018666210208163946","article-title":"Promoter Methylation and Gene Expression of Pin1 Associated with the Risk of Alzheimer\u2019s Disease in Southern Chinese","volume":"17","author":"Ma","year":"2020","journal-title":"Curr. Alzheimer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbrc.2014.10.101","article-title":"p53 negatively regulates Pin1 expression under ER stress","volume":"454","author":"Jeong","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1021\/acsomega.3c07285","article-title":"cis P-tau Accumulation Triggers Neurodegeneration after Ischemic Stroke","volume":"9","author":"Seddigh","year":"2024","journal-title":"ACS Omega"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Katsumoto, A., Takeuchi, H., and Tanaka, F. (2019). Tau Pathology in Chronic Traumatic Encephalopathy and Alzheimer\u2019s Disease: Similarities and Differences. Front. Neurol., 10.","DOI":"10.3389\/fneur.2019.00980"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","article-title":"Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer\u2019s Disease","volume":"36","author":"Lian","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1074\/jbc.M110.209296","article-title":"Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles","volume":"286","author":"Guo","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1039\/D4SC06762B","article-title":"Multi-target-directed therapeutic strategies for Alzheimer\u2019s disease: Controlling amyloid-beta aggregation, metal ion homeostasis, and enzyme inhibition","volume":"16","author":"Yoo","year":"2025","journal-title":"Chem. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/s40001-025-02886-9","article-title":"Pathological mechanisms and treatment progression of Alzheimer\u2019s disease","volume":"30","author":"Zhang","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41582-025-01123-5","article-title":"Amyloid-lowering immunotherapies for Alzheimer disease: Current status and future directions","volume":"21","author":"Rafii","year":"2025","journal-title":"Nat. Rev. Neurol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","article-title":"Association of Amyloid and Tau with Cognition in Preclinical Alzheimer Disease: A Longitudinal Study","volume":"76","author":"Hanseeuw","year":"2019","journal-title":"JAMA Neurol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1038\/s41380-021-01263-2","article-title":"Alzheimer\u2019s disease profiled by fluid and imaging markers: Tau PET best predicts cognitive decline","volume":"26","author":"Bucci","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Papaliagkas, V. (2025). Anti-Amyloid Therapies for Alzheimer\u2019s Disease: Progress, Pitfalls, and the Path Ahead. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26199529"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0304-3940(92)90774-2","article-title":"Glycogen synthase kinase-3 induces Alzheimer\u2019s disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase","volume":"147","author":"Hanger","year":"1992","journal-title":"Neurosci. Lett."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/45159","article-title":"Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration","volume":"402","author":"Patrick","year":"1999","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neurobiolaging.2005.11.009","article-title":"PIN1 promoter polymorphisms are associated with Alzheimer\u2019s disease","volume":"28","author":"Segat","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.neuron.2024.01.024","article-title":"Mechanisms of sex differences in Alzheimer\u2019s disease","volume":"112","author":"Torres","year":"2024","journal-title":"Neuron"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"eadi8743","DOI":"10.1126\/scisignal.adi8743","article-title":"Pin1-catalyzed conformational regulation after phosphorylation: A distinct checkpoint in cell signaling and drug discovery","volume":"17","author":"Lu","year":"2024","journal-title":"Sci. Signal."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1002\/alz.13028","article-title":"Preclinical characterization and IND-enabling safety studies for PNT001, an antibody that recognizes cis-pT231 tau","volume":"19","author":"Foster","year":"2023","journal-title":"Alzheimers Dement."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3233\/JAD-220159","article-title":"Traumatic Brain Injury and Risk of Alzheimer\u2019s Disease and Related Dementias in the Population","volume":"88","author":"Mielke","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Li, Y., Li, Y., Li, X., Zhang, S., Zhao, J., Zhu, X., and Tian, G. (2017). Head Injury as a Risk Factor for Dementia and Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis of 32 Observational Studies. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0169650"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000520966","article-title":"Traumatic Brain Injury and Risk of Dementia and Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"56","author":"Gu","year":"2022","journal-title":"Neuroepidemiology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1365-2990.2003.00488.x","article-title":"Tau immunohistochemistry in acute brain injury","volume":"29","author":"Smith","year":"2003","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01616412.2021.2022921","article-title":"Pathogenic cis p-tau levels in CSF reflects severity of traumatic brain injury","volume":"44","author":"Jahanbakhshi","year":"2022","journal-title":"Neurol. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/alzrt234","article-title":"Chronic traumatic encephalopathy: A spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel","volume":"6","author":"Stein","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.csm.2010.09.007","article-title":"Chronic traumatic encephalopathy: A potential late effect of sport-related concussive and subconcussive head trauma","volume":"30","author":"Gavett","year":"2011","journal-title":"Clin. Sports Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1007\/s00415-023-11614-4","article-title":"Is dementia more likely following traumatic brain injury? A systematic review","volume":"270","author":"Hanrahan","year":"2023","journal-title":"J. Neurol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neurobiolaging.2021.08.011","article-title":"Distinct phosphorylation profiles of tau in brains of patients with different tauopathies","volume":"108","author":"Samimi","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"ref_107","unstructured":"(2024). GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol., 23, 973\u20131003."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","article-title":"Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: A systematic review and meta-analysis","volume":"8","author":"Pendlebury","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/CIRCRESAHA.116.308426","article-title":"Vascular Cognitive Impairment","volume":"120","author":"Dichgans","year":"2017","journal-title":"Circ. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1042\/CS20160727","article-title":"Chronic cerebral hypoperfusion: A key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia","volume":"131","author":"Duncombe","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"114834","DOI":"10.1016\/j.intimp.2025.114834","article-title":"Anti-cis P-tau attenuates tauopathy and enhances cognitive function following global cerebral ischemia in mice","volume":"158","author":"Sadeghzadeh","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1161\/01.STR.0000143725.19053.60","article-title":"White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion","volume":"35","author":"Shibata","year":"2004","journal-title":"Stroke"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"14002","DOI":"10.1523\/JNEUROSCI.1592-15.2015","article-title":"Astrocytes Promote Oligodendrogenesis after White Matter Damage via Brain-Derived Neurotrophic Factor","volume":"35","author":"Miyamoto","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.expneurol.2015.05.006","article-title":"Models and mechanisms of vascular dementia","volume":"272","author":"Venkat","year":"2015","journal-title":"Exp. Neurol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"32179","DOI":"10.1038\/srep32179","article-title":"Substantial Reduction of Parenchymal Cerebral Blood Flow in Mice with Bilateral Common Carotid Artery Stenosis","volume":"6","author":"Hattori","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","article-title":"Pre-eclampsia","volume":"398","author":"Chappell","year":"2021","journal-title":"Lancet"},{"key":"ref_117","unstructured":"The World Health Organization (2026, May 16). Pre-Eclampsia. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/pre-eclampsia."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"k4109","DOI":"10.1136\/bmj.k4109","article-title":"Pre-eclampsia and risk of dementia later in life: Nationwide cohort study","volume":"363","author":"Basit","year":"2018","journal-title":"BMJ"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ajog.2024.01.013","article-title":"Hypertensive disorders of pregnancy and the risk of maternal dementia: A systematic review and meta-analysis","volume":"231","author":"Carey","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13578-026-01540-z","article-title":"The impact and mechanisms of preeclampsia on offspring neurodevelopment","volume":"16","author":"Zhang","year":"2026","journal-title":"Cell Biosci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jamapsychiatry.2020.0306","article-title":"Association of Preeclampsia in Term Births With Neurodevelopmental Disorders in Offspring","volume":"77","author":"Sun","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: Pathogenesis, novel diagnostics and therapies","volume":"15","author":"Phipps","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Nalivaeva, N.N., Turner, A.J., and Zhuravin, I.A. (2018). Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00825"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Cheron, J., Ranga, A., and Bonnefont, J. (2026). Are neurodegenerative diseases late-onset neurodevelopmental disorders? Tracing the developmental origins of neuronal vulnerability. Front. Neurosci., 20.","DOI":"10.3389\/fnins.2026.1729102"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/HYPERTENSIONAHA.122.19408","article-title":"Brain Vascular Dysfunction in Mothers and Their Children Exposed to Preeclampsia","volume":"80","author":"Escudero","year":"2023","journal-title":"Hypertension"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5582\/ddt.2025.01055","article-title":"The pTau217\/Abeta(1-42) plasma ratio: The first FDA-cleared blood biomarker test for diagnosis of Alzheimer\u2019s disease","volume":"19","author":"Hu","year":"2025","journal-title":"Drug Discov. Ther."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma p-tau231: A new biomarker for incipient Alzheimer\u2019s disease pathology","volume":"141","author":"Ashton","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12035-019-01698-3","article-title":"Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders","volume":"57","author":"Alirezaei","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: Mapping the road to the clinic","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: Towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer\u2019s disease in clinical practice and trials","volume":"3","author":"Hansson","year":"2023","journal-title":"Nat. Aging"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","article-title":"A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer\u2019s disease","volume":"26","author":"Barthelemy","year":"2020","journal-title":"Nat. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1002\/alz.14184","article-title":"Recommendations for clinical implementation of blood-based biomarkers for Alzheimer\u2019s disease","volume":"20","author":"Mielke","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e70752","DOI":"10.1002\/alz.70752","article-title":"Evidence-based standardized sample handling protocol for accurate blood-based Alzheimer\u2019s disease biomarker measurement: Results and consensus of the Global Biomarker Standardization Consortium","volume":"21","author":"Verberk","year":"2025","journal-title":"Alzheimers Dement."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Shiravandi, A., Yari, F., Tofigh, N., Kazemi Ashtiani, M., Shahpasand, K., Ghanian, M.H., Shekari, F., and Faridbod, F. (2022). Earlier Detection of Alzheimer\u2019s Disease Based on a Novel Biomarker cis P-tau by a Label-Free Electrochemical Immunosensor. Biosensors, 12.","DOI":"10.3390\/bios12100879"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"366","DOI":"10.14283\/jpad.2024.25","article-title":"A Phase 1 Single-Ascending-Dose Trial in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravenous PNT001, a Novel Mid-domain Tau Antibody Targeting cis-pT231 Tau","volume":"11","author":"Luca","year":"2024","journal-title":"J. Prev. Alzheimers Dis."},{"key":"ref_138","unstructured":"Pinteon Therapeutics, Inc. (2020). Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending-Dose Trial to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of Intravenous PNT001 in Hospitalized Patients with Traumatic Brain Injury (TBI), ClinicalTrials.gov Registration Number: NCT04677829."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40265-015-0529-0","article-title":"Tau Biology and Tau-Directed Therapies for Alzheimer\u2019s Disease","volume":"76","author":"Bakota","year":"2016","journal-title":"Drugs"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1326-9-29","article-title":"Motor and cognitive deficits in aged tau knockout mice in two background strains","volume":"9","author":"Lei","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Goncalves, R.A., Wijesekara, N., Fraser, P.E., and De Felice, F.G. (2020). Behavioral Abnormalities in Knockout and Humanized Tau Mice. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00124"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"11","DOI":"10.20517\/and.2022.16","article-title":"Tau-targeting therapy in Alzheimer\u2019s disease: Critical advances and future opportunities","volume":"2","author":"Guo","year":"2022","journal-title":"Ageing Neurodegener. Dis."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-022-00702-0","article-title":"The challenges of anti-tau therapeutics in Alzheimer disease","volume":"18","author":"Panza","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/s43587-023-00523-w","article-title":"TANGO: A placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer\u2019s disease","volume":"3","author":"Shulman","year":"2023","journal-title":"Nat. Aging"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Yang, H.M. (2025). Recent Advances in Antibody Therapy for Alzheimer\u2019s Disease: Focus on Bispecific Antibodies. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26136271"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12035-025-05417-z","article-title":"Targeted Nanoparticles for Drug Delivery Across the Blood-Brain Barrier in Early and Late Stages of Alzheimer\u2019s Disease: A Review","volume":"63","author":"Kochman","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Soleimanizadeh, A., Dinter, H., and Schindowski, K. (2021). Central Nervous System Delivery of Antibodies and Their Single-Domain Antibodies and Variable Fragment Derivatives with Focus on Intranasal Nose to Brain Administration. Antibodies, 10.","DOI":"10.3390\/antib10040047"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1038\/s41467-025-59447-1","article-title":"Leveraging neonatal Fc receptor (FcRn) to enhance antibody transport across the blood brain barrier","volume":"16","author":"Sadekar","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Ding, L., Kshirsagar, P., Agrawal, P., and Murry, D.J. (2025). Crossing the Blood-Brain Barrier: Innovations in Receptor- and Transporter-Mediated Transcytosis Strategies. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17060706"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Wang, L., Zhou, Y., Chen, D., and Lee, T.H. (2020). Peptidyl-Prolyl Cis\/Trans Isomerase Pin1 and Alzheimer\u2019s Disease. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00355"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40035-024-00429-6","article-title":"Tau in neurodegenerative diseases: Molecular mechanisms, biomarkers, and therapeutic strategies","volume":"13","author":"Zhang","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Virgilio, E., De Marchi, F., Contaldi, E., Dianzani, U., Cantello, R., Mazzini, L., and Comi, C. (2022). The Role of Tau beyond Alzheimer\u2019s Disease: A Narrative Review. Biomedicines, 10.","DOI":"10.3390\/biomedicines10040760"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Wasilewski, T., Kamysz, W., and Gebicki, J. (2024). AI-Assisted Detection of Biomarkers by Sensors and Biosensors for Early Diagnosis and Monitoring. Biosensors, 14.","DOI":"10.3390\/bios14070356"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"102954","DOI":"10.1016\/j.arr.2025.102954","article-title":"Next-generation biosensor technologies for Alzheimer\u2019s disease: Innovations in diagnosis, monitoring, and treatment","volume":"114","author":"Yin","year":"2026","journal-title":"Ageing Res. Rev."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/18\/1650\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:19:35Z","timestamp":1789445975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/18\/1650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":154,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cells15181650"],"URL":"https:\/\/doi.org\/10.3390\/cells15181650","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]}}}